Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingjie Tuire Granules (清解退热颗粒) is a Traditional Chinese Medicine (TCM) formulation widely used in China for its antipyretic and anti-inflammatory properties. It is primarily indicated for the treatment of fever, sore throat, and upper respiratory tract infections caused by wind-heat pathogens. The formulation typically includes a blend of botanical extracts such as *Lonicera japonica* (honeysuckle), *Forsythia suspensa*, *Isatis tinctoria* (woad root), and mineral components like *Gypsum fibrosum*. These ingredients are traditionally believed to clear internal heat and detoxify the body. It is manufactured by several pharmaceutical companies, including Harbin Pharmaceutical Group, and is available as an over-the-counter or prescription granule for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingjie Tuire Granules.